BM
Brandywine Managers’s Beam Therapeutics BEAM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $316K | Buy |
18,606
+7,300
| +65% | +$124K | 0.31% | 27 |
|
2025
Q1 | $221K | Hold |
11,306
| – | – | 0.26% | 31 |
|
2024
Q4 | $280K | Hold |
11,306
| – | – | 0.3% | 32 |
|
2024
Q3 | $277K | Buy |
+11,306
| New | +$277K | 0.3% | 30 |
|
2024
Q2 | – | Sell |
-8,067
| Closed | -$267K | – | 37 |
|
2024
Q1 | $267K | Hold |
8,067
| – | – | 0.26% | 33 |
|
2023
Q4 | $220K | Buy |
+8,067
| New | +$220K | 0.24% | 38 |
|
2023
Q3 | – | Sell |
-8,067
| Closed | -$258K | – | 40 |
|
2023
Q2 | $258K | Hold |
8,067
| – | – | 0.17% | 44 |
|
2023
Q1 | $247K | Hold |
8,067
| – | – | 0.18% | 44 |
|
2022
Q4 | $316K | Sell |
8,067
-5,000
| -38% | -$196K | 1.1% | 30 |
|
2022
Q3 | $623K | Hold |
13,067
| – | – | 2.05% | 17 |
|
2022
Q2 | $506K | Hold |
13,067
| – | – | 1.24% | 25 |
|
2022
Q1 | $749K | Buy |
13,067
+167
| +1% | +$9.57K | 1.29% | 23 |
|
2021
Q4 | $1.03M | Hold |
12,900
| – | – | 1.16% | 18 |
|
2021
Q3 | $1.12M | Hold |
12,900
| – | – | 1.17% | 16 |
|
2021
Q2 | $1.66M | Buy |
12,900
+1,833
| +17% | +$236K | 1.89% | 10 |
|
2021
Q1 | $886K | Buy |
11,067
+192
| +2% | +$15.4K | 1.18% | 20 |
|
2020
Q4 | $888K | Hold |
10,875
| – | – | 1.22% | 17 |
|
2020
Q3 | $268K | Hold |
10,875
| – | – | 0.51% | 33 |
|
2020
Q2 | $305K | Sell |
10,875
-4,425
| -29% | -$124K | 1.25% | 30 |
|
2020
Q1 | $275K | Buy |
+15,300
| New | +$275K | 0.1% | 23 |
|